Miklós Gulyás

731 total citations
28 papers, 509 citations indexed

About

Miklós Gulyás is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Miklós Gulyás has authored 28 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Miklós Gulyás's work include Occupational and environmental lung diseases (5 papers), Medical Imaging and Pathology Studies (5 papers) and Immunotherapy and Immune Responses (4 papers). Miklós Gulyás is often cited by papers focused on Occupational and environmental lung diseases (5 papers), Medical Imaging and Pathology Studies (5 papers) and Immunotherapy and Immune Responses (4 papers). Miklós Gulyás collaborates with scholars based in Sweden, Hungary and France. Miklós Gulyás's co-authors include Anders Hjerpe, Patrick Micke, Katalin Dobra, Hans Brunnström, Max Backman, Sofia Westbom-Fremer, Dijana Djureinovic, Xiaojuan Sun, Annika Dejmek and Johanna Sofia Margareta Mattsson and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Miklós Gulyás

26 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miklós Gulyás Sweden 12 203 196 141 69 66 28 509
Xiaojing Yang China 14 167 0.8× 145 0.7× 209 1.5× 61 0.9× 92 1.4× 55 594
David Barron United States 8 142 0.7× 229 1.2× 215 1.5× 71 1.0× 120 1.8× 13 559
Coralie Moncharmont France 9 204 1.0× 160 0.8× 157 1.1× 25 0.4× 83 1.3× 26 437
Xinhai Wan United States 9 208 1.0× 185 0.9× 235 1.7× 39 0.6× 119 1.8× 10 503
Ji‐Han Jung South Korea 15 282 1.4× 140 0.7× 265 1.9× 67 1.0× 119 1.8× 34 667
Stephan Seitz Germany 14 216 1.1× 84 0.4× 155 1.1× 40 0.6× 77 1.2× 44 512
Tatsuya Shimomura Japan 9 173 0.9× 265 1.4× 203 1.4× 25 0.4× 87 1.3× 37 469
Faith Nutter United Kingdom 9 231 1.1× 82 0.4× 157 1.1× 78 1.1× 63 1.0× 12 466
Masato Aragaki Japan 12 177 0.9× 244 1.2× 379 2.7× 40 0.6× 121 1.8× 48 683
Karin Jennbacken Sweden 20 248 1.2× 256 1.3× 469 3.3× 98 1.4× 173 2.6× 33 816

Countries citing papers authored by Miklós Gulyás

Since Specialization
Citations

This map shows the geographic impact of Miklós Gulyás's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miklós Gulyás with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miklós Gulyás more than expected).

Fields of papers citing papers by Miklós Gulyás

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miklós Gulyás. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miklós Gulyás. The network helps show where Miklós Gulyás may publish in the future.

Co-authorship network of co-authors of Miklós Gulyás

This figure shows the co-authorship network connecting the top 25 collaborators of Miklós Gulyás. A scholar is included among the top collaborators of Miklós Gulyás based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miklós Gulyás. Miklós Gulyás is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Backman, Max, Carina Strell, Johanna Sofia Margareta Mattsson, et al.. (2022). Spatial Immunophenotyping of the Tumor Microenvironment in Non-Small Cell Lung Cancer. SSRN Electronic Journal.
2.
Micke, Patrick, Hui Yu, Rosemarie Krupar, et al.. (2022). Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas. Translational Lung Cancer Research. 11(12). 2477–2494. 2 indexed citations
3.
Milosevic, Jelena, Susanne Fransson, Miklós Gulyás, et al.. (2021). High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice. Cancers. 13(21). 5493–5493. 8 indexed citations
4.
Thor, Andreas, et al.. (2021). Localized IgG4-related disease manifested on the tongue: a case report. Upsala Journal of Medical Sciences. 126(1). 2 indexed citations
5.
Ghosh, Krishna, Sachin Mishra, Miklós Gulyás, et al.. (2020). Targeted pancreatic beta cell imaging for early diagnosis. European Journal of Cell Biology. 99(7). 151110–151110. 4 indexed citations
6.
Gulyás, Miklós, János Fillinger, András D. Kaposi, & Miklós Molnár. (2019). Use of cholesterol and soluble tumour markers CEA and syndecan-2 in pleural effusions in cases of inconclusive cytology. Journal of Clinical Pathology. 72(8). 529–535. 1 indexed citations
7.
Mishra, Sachin, Miklós Gulyás, P. Mahalakshmi, et al.. (2019). Blood brain barrier: A tissue engineered microfluidic chip. Journal of Neuroscience Methods. 331. 108525–108525. 23 indexed citations
8.
Mishra, Sachin, et al.. (2017). An Overview of Multimodal Neuroimaging Using Nanoprobes. International Journal of Molecular Sciences. 18(2). 311–311. 7 indexed citations
9.
Gulyás, Miklós, Johanna Sofia Margareta Mattsson, Andrea Lindgren, et al.. (2017). COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer. Acta Oncologica. 57(2). 244–250. 21 indexed citations
10.
Brunnström, Hans, Sofia Westbom-Fremer, Max Backman, et al.. (2017). PD-L1 immunohistochemistry in clinical diagnostics of lung cancer: inter-pathologist variability is higher than assay variability. Modern Pathology. 30(10). 1411–1421. 159 indexed citations
11.
Micke, Patrick, et al.. (2017). PD-L1 immunohistochemistry in clinical diagnostics: Inter-pathologist variability is as high as assay variability.. Journal of Clinical Oncology. 35(15_suppl). e20637–e20637. 2 indexed citations
12.
Mattsson, Johanna Sofia Margareta, Bengt Bergman, Marianna Grinberg, et al.. (2014). Prognostic impact of COX-2 in non-small cell lung cancer: A comprehensive compartment-specific evaluation of tumor and stromal cell expression. Cancer Letters. 356(2). 837–845. 18 indexed citations
13.
Gulyás, Miklós, et al.. (2009). A recruitment breath manoeuvre directly after endotracheal suction improves lung function: An experimental study in pigs. Upsala Journal of Medical Sciences. 114(3). 129–135. 4 indexed citations
14.
Sun, Xiaojuan, Miklós Gulyás, Anders Hjerpe, & Katalin Dobra. (2005). Proteasome inhibitor PSI induces apoptosis in human mesothelioma cells. Cancer Letters. 232(2). 161–169. 24 indexed citations
15.
Sun, Xiaojuan, Miklós Gulyás, & Anders Hjerpe. (2003). Mesothelial Differentiation as Reflected by Differential Gene Expression. American Journal of Respiratory Cell and Molecular Biology. 30(4). 510–518. 29 indexed citations
16.
Gulyás, Miklós & Anders Hjerpe. (2003). Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium. The Journal of Pathology. 199(4). 479–487. 69 indexed citations
17.
Gulyás, Miklós, András D. Kaposi, Gábor Elek, Lajos Szollár, & Anders Hjerpe. (2001). Value of carcinoembryonic antigen (CEA) and cholesterol assays of ascitic fluid in cases of inconclusive cytology. Journal of Clinical Pathology. 54(11). 831–835. 22 indexed citations
18.
Gulyás, Miklós, Katalin Dobra, & Anders Hjerpe. (1999). Expression of genes coding for proteoglycans and Wilms' tumour susceptibility gene 1 (WT1) by variously differentiated benign human mesothelial cells. Differentiation. 65(2). 89–96. 17 indexed citations
19.
Gulyás, Miklós, Katalin Dobra, & Anders Hjerpe. (1999). Expression of genes coding for proteoglycans and Wilms’ tumour susceptibility gene 1 (WT1) by variously differentiated benign human mesothelial cells. Differentiation. 65(2). 89–89. 2 indexed citations
20.
Gulyás, Miklós, Gábor Elek, Miklós Molnár, & Lajos Szollár. (1995). [Oncologic diagnosis of serous effusions in body cavities (cytologic study and evaluation of cholesterol and carcinoembryonic antigen levels)].. PubMed. 136(45). 2453–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaojing Yang Breakdown of academic impact, for papers by David Barron Breakdown of academic impact, for papers by Coralie Moncharmont Breakdown of academic impact, for papers by Xinhai Wan Breakdown of academic impact, for papers by Ji‐Han Jung Breakdown of academic impact, for papers by Stephan Seitz Breakdown of academic impact, for papers by Tatsuya Shimomura Breakdown of academic impact, for papers by Faith Nutter Breakdown of academic impact, for papers by Masato Aragaki Breakdown of academic impact, for papers by Karin Jennbacken
Rankless by CCL
2026